Global Breast Cancer Liquid Biopsy Market to Reach $963.2 Million by 2030
The global market for Breast Cancer Liquid Biopsy estimated at US$248.6 Million in the year 2023, is expected to reach US$963.2 Million by 2030, growing at a CAGR of 21.3% over the analysis period 2023-2030. Reagent Kits, one of the segments analyzed in the report, is expected to record a 21.8% CAGR and reach US$730.5 Million by the end of the analysis period. Growth in the Instruments segment is estimated at 20.9% CAGR for the next 7-year period.
The U.S. Market is Estimated at $77 Million, While China is Forecast to Grow at 20.4% CAGR
The Breast Cancer Liquid Biopsy market in the U.S. is estimated at US$77 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$161.4 Million by the year 2030 trailing a CAGR of 20.4% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 19.1% and 18.3% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 15.6% CAGR.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook